Medicine and Dentistry
Patient
73%
Assay
64%
COVID-19
43%
Plasma
34%
Vaccine
33%
Therapeutic Procedure
31%
Thrombosis
29%
Blood Stasis
28%
Thrombin
28%
Coagulation
27%
Assessment
26%
Inpatient
26%
Cells
25%
Laboratory
25%
Endothelial Cell
24%
Woman
23%
Severe Acute Respiratory Syndrome Coronavirus 2
23%
In Vitro
22%
Diagnosis
21%
Direct Oral Anticoagulant
21%
COVID-19 Vaccination
21%
Neutralizing Antibody
21%
Neutrophil
19%
Thrombocytopenia
19%
Analysis
19%
Procoagulant
19%
Heparin
17%
Antithrombotic
17%
Infection
16%
Bleeding
16%
Biological Marker
16%
Combination Therapy
16%
Syndrome
16%
Coagulopathy
15%
Platelet
15%
Activated Protein C Resistance
15%
Betrixaban
15%
Membrane Microparticle
14%
Tyrosine-Kinase Inhibitor
14%
Oral Contraceptive
14%
Case Report
14%
Estetrol
14%
Cell Survival
14%
Cell Function
14%
Thromboplastin
13%
Measurement
13%
Antibody
13%
Hemostat
13%
Donor
12%
Low Molecular Weight Heparin
12%
Venous Thromboembolism
12%
Ex Vivo
11%
Erythrocyte
11%
Blood Clotting Factor 10a Inhibitor
11%
Diagnostic Test
11%
Blood Clotting Test
10%
Age
10%
Antigen
10%
Dabigatran
9%
Heparin-Induced Thrombocytopenia
9%
Anticoagulation
9%
Cell Adhesion Molecule
9%
Malignant Neoplasm
9%
Edoxaban
9%
Apixaban
9%
Screening
8%
Disseminated Intravascular Coagulation
8%
Leukemia Cell
8%
Liquid Chromatography-Mass Spectrometry
8%
Thrombocyte Activation
8%
Blood
8%
Contraceptive Agent
8%
Hemolysis
8%
Pathophysiology
8%
Dasatinib
8%
Acute Leukemia
8%
Danaparoid
8%
Observational Study
8%
Vascular Endothelium
8%
Acute Myeloid Leukemia
8%
Monitoring
8%
Thrombocyte Function
7%
Thrombophilia
7%
Human
7%
Thromboembolism
7%
Serum
7%
Ponatinib
7%
Mortality
7%
microRNA
7%
Neoplasm
7%
Phenotype
7%
Lipoxygenase Inhibitor
7%
Coumarin Derivative
7%
Fat Intake
7%
Hexadimethrine Bromide
7%
Activated Charcoal
7%
Sinus Surgery
7%
Masking
7%
Erythrocyte Concentrate
7%
Decision Making
7%
Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
100%
Anticoagulant Agent
83%
Rivaroxaban
57%
Dabigatran
41%
Antivitamin K
41%
Thrombin
37%
Blood Clotting Factor 10a Inhibitor
33%
Malignant Neoplasm
32%
Drug
30%
Thromboembolism
30%
Apixaban
29%
Bleeding
29%
Protein Tyrosine Kinase Inhibitor
28%
Heparin
26%
Atrial Fibrillation
24%
Low Molecular Weight Heparin
22%
Prospective Study
21%
Viper Venom
21%
Daboia russellii
20%
Edoxaban
20%
Reagent
19%
Emergency
17%
Diseases
17%
Chronic Myeloid Leukemia
17%
Betrixaban
17%
Dabigatran Etexilate
16%
Nanoparticle
16%
Thrombin Inhibitor
14%
Warfarin
14%
Activated Protein C Resistance
14%
Paroxysmal Nocturnal Hemoglobinuria
14%
Survival
14%
Ponatinib
14%
Nilotinib
14%
Prothrombin
14%
Dasatinib
14%
Ensure
13%
Thromboplastin
13%
Inflammation
13%
Clotting Time
12%
Carboline Derivative
12%
Venous Thromboembolism
12%
Silicon Carbide
11%
Adverse Drug Reaction
11%
Thrombosis
11%
Clinical Study
11%
Hemolysis
11%
Metal
10%
Blood Clotting Disorder
10%
Structure Activity Relationship
10%
Pharmacodynamics
10%
Toxic Injury
9%
Acute Leukemia
9%
COVID-19 Vaccine
9%
Ligand
8%
Nanomaterial
8%
Procoagulant
8%
Pharmacokinetics
8%
Drug Interaction
8%
Eculizumab
8%
Apigenin
8%
Drug Concentration
8%
Randomized Controlled Trial
8%
SARS Coronavirus
8%
Coronavirinae
8%
Andexanet Alfa
8%
Rat
8%
Ethanol
7%
Protein
7%
Heart Infarction
7%
Clinical Trial
7%
Active Metabolite
7%
Indoleamine
7%
Disseminated Intravascular Clotting
7%
Menopausal Syndrome
7%
Phenyl Group
7%
Menopause
7%
Pharmacovigilance
7%
Tissue Factor Pathway Inhibitor
7%
Carbonate Dehydratase IX
7%
Carbide
7%
Genotoxicity
7%
Long Term Survival
7%
Hexadimethrine Bromide
7%
Ixodes ricinus
7%
Tick
7%
Monoamine Oxidase Inhibitor
7%
Amine Oxidase (Flavin Containing) Isoenzyme A
7%
Rupture
7%
Capillary Electrophoresis
7%
Lipoxygenase Inhibitor
7%
Recombinant Interleukin 2
7%
Blood Clotting Factor 12
7%
Acute Myeloid Leukemia
7%
Multidrug Resistance Protein 1
7%
Lactic Acid
7%
Cohort Study
7%
Indoleamine 2,3 Dioxygenase Inhibitor
7%
Antiinfective Agent
7%
Phosphoglycerate Dehydrogenase
7%
Biochemistry, Genetics and Molecular Biology
Thrombin
52%
Coagulation
50%
Thrombocyte Aggregation
21%
Sample
21%
Blood Level
19%
Time
17%
Activated Protein C Resistance
14%
D-Dimer
14%
Taxonomy
14%
Tyrosine Kinase Inhibitor
14%
Nucleosome
14%
Hemostasis
12%
Electric Potential
11%
Vitamin K
11%
Cancer Cell
11%
Phenotype
10%
Anticoagulation
10%
Overall Survival
9%
Coagulation System
9%
Screening
9%
Protein
9%
Development
9%
Myeloid
8%
Light
8%
Partial Thromboplastin Time
8%
Immune Response
8%
Ponatinib
8%
Disseminated Intravascular Coagulation
7%
Aptitude
7%
Histone
7%
Molecule
7%
Molecular Weight
7%
Plasma Factor
7%
Plasma Kallikrein
7%
Tissue Factor Pathway Inhibitor
7%
Tick
7%
Ixodes ricinus
7%
High Throughput Screening
7%
Histone Deacetylase 5
7%
Cisplatin
7%
Thrombocyte Function
7%
Laboratory Test
7%
Cell Survival
7%
Vitamin
7%
Quality Control
7%
Structure Activity Relation
7%
Thrombin Time
7%
Capillary Electrophoresis
7%
Disulfide
7%
Coumarin
7%
Thrombotic Microangiopathy
7%
Association
7%
All Cause Mortality
7%
Benzothiadiazine
7%
Factor XII
7%
Small Interfering RNA
7%
Synthesis
7%
Heparin-Induced Thrombocytopenia
7%
Cell Function
7%
Solution and Solubility
7%
Nilotinib
7%
Growth
7%
Rat Model
7%
Magnetic Resonance Imaging
7%
Dilute Russell's Viper Venom Time
7%
Thromboxane B2
7%
Atrial Fibrillation
7%
Mass Spectrometry
7%
Terlipressin
7%
Posttranslational Modification
7%
Relapse
7%
Clinical Study
7%
MicroRNA
7%
Experiment
6%
Dasatinib
6%
Adhesion
5%
Liquid
5%